[Skip to Navigation]
Viewpoint
October 2017

Tying Reimbursement to Outcomes Is an Ideal Strategy for PCSK9 Inhibitors

Author Affiliations
  • 1Cardiology Division, Massachusetts General Hospital, Boston
  • 2Harvard Medical School, Boston, Massachusetts
  • 3Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles
  • 4RAND Corporation, Santa Monica, California
  • 5Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
  • 6Department of Medicine, Massachusetts General Hospital, Boston
  • 7National Bureau of Economic Research, Cambridge, Massachusetts
JAMA Cardiol. 2017;2(10):1063-1064. doi:10.1001/jamacardio.2017.2959
Add or change institution
×